Association between gout and all-cause as well as cardiovascular mortality: a systematic review.

Current Rheumatology Reports
Kathrin LottmannPeter K Schädlich

Abstract

Gout affects 1% to 2% of the population, and the prevalence is increasing due to changes in diet and the ageing of the population. Its development and risk factors have been explored frequently, and recommendations for the diagnosis and management of gout implemented. Nevertheless, there is a lack of knowledge regarding the long-term impact on gouty patients. This systematic review therefore evaluates the association between gout and all-cause as well as cardiovascular mortality. A systematic literature search was performed, and seven long-term studies were ultimately analyzed. Six of them used multivariate regressions to assess the adjusted mortality ratio in gouty patients with reference to patients without the disorder. Despite differences in study designs, study populations, and definitions of gout, the results were consistent: There was an independent association between gout and all-cause as well as cardiovascular mortality. Knowing that patients with gout are at risk emphasizes the need for adequate care.

References

Jan 1, 1988·Journal of Clinical Epidemiology·R D AbbottW P Castelli
Jan 1, 1980·Advances in Experimental Medicine and Biology·N Nishioka, K Mikanagi
Sep 23, 2003·Health Technology Assessment : HTA·J J DeeksUNKNOWN European Carotid Surgery Trial Collaborative Group
Dec 13, 2005·Transplantation·Kevin C AbbottSophie Caillard
Feb 8, 2006·Current Opinion in Rheumatology·Ted R Mikuls, Kenneth G Saag
May 19, 2006·Annals of the Rheumatic Diseases·W ZhangUNKNOWN EULAR Standing Committee for International Clinical Studies Including Therapeutics
May 19, 2006·Annals of the Rheumatic Diseases·W ZhangUNKNOWN EULAR Standing Committee for International Clinical Studies Including Therapeutics
Jul 28, 2006·Arthritis and Rheumatism·Eswar KrishnanH Ralph Schumacher
Aug 19, 2007·Circulation·Hyon K Choi, Gary Curhan
Oct 17, 2007·Annals of Internal Medicine·Jan P VandenbrouckeUNKNOWN STROBE initiative
Oct 19, 2007·PLoS Medicine·Jan P VandenbrouckeUNKNOWN STROBE Initiative
May 28, 2008·Archives of Internal Medicine·Eswar KrishnanUNKNOWN MRFIT Research Group
May 30, 2008·Journal of the American Society of Nephrology : JASN·Scott D CohenKevin C Abbott
Nov 13, 2009·Rheumatology·Michael Doherty
Jun 13, 2009·Arthritis Research & Therapy·Sherine E Gabriel, Kaleb Michaud
Oct 2, 2009·Deutsches Ärzteblatt International·Anne-Kathrin TauscheUlf Müller-Ladner
Oct 8, 2009·Rheumatology·Tom G Rider, Kelsey M Jordan
Nov 26, 2009·Rheumatology·Chang-Fu KuoKuang-Hui Yu
Aug 11, 2010·Archives of Internal Medicine·George ThanassoulisLouise Pilote
Aug 31, 2010·Rheumatology·Lisa G RiderUNKNOWN Childhood Myositis Heterogeneity Collaborative Study Group
Dec 18, 2010·Current Rheumatology Reports·José M A WijnandsSjef van der Linden
Nov 1, 2009·Journal of Evidence-based Medicine·Mike Clarke, Li Youping
Jun 28, 2011·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Linda J Koenig, Donna Hubbard McCree

❮ Previous
Next ❯

Citations

Oct 30, 2012·Advances in Therapy·Fernando Perez-Ruiz, Ana Maria Herrero-Beites
Apr 9, 2013·QJM : Monthly Journal of the Association of Physicians·A G StackH T Nguyen
Aug 20, 2014·Nature Reviews. Rheumatology·Pascal RichetteThomas Bardin
Apr 4, 2014·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Davide GrassiGiovambattista Desideri
Jan 17, 2013·Postgraduate Medicine·Paul P Doghramji, Robert L Wortmann
Sep 6, 2013·Expert Opinion on Therapeutic Targets·Zhenyu ZhongLiang Qiao
Nov 16, 2014·Annals of the Rheumatic Diseases·Chang-Fu KuoMichael Doherty
Aug 14, 2012·Autoimmunity Reviews·Leonardo PunziFrancesca Oliviero
Mar 31, 2016·Journal of Managed Care & Specialty Pharmacy·Ghaith MitriKathy L Schulman
Jun 20, 2015·European Journal of Internal Medicine·Chao-Yu HsuChia-Hung Kao
Jul 9, 2016·Obesity Surgery·Federico MarchesiLuigi Roncoroni
Nov 28, 2013·European Journal of Preventive Cardiology·L E ClarsonC D Mallen
Oct 5, 2018·Rheumatology·Esther EbsteinSébastien Ottaviani
Feb 15, 2014·Clinical Nutrition Research·Kyoung A RyuGyung Ah Wie
Oct 18, 2018·Expert Review of Clinical Pharmacology·Bogusław OkopieńAleksandra Bołdys
Feb 17, 2015·The Journal of Rheumatology·Jessica A WalshBrian Sauer
Jul 4, 2012·The Journal of Rheumatology·Lesley A SaketkooLuis R Espinoza
Dec 12, 2019·Tropical Medicine & International Health : TM & IH·Felix P ChilungaCharles Agyemang
Nov 6, 2018·International Journal of STD & AIDS·Prini NicholsonKaren Walker-Bone
May 31, 2016·Terapevticheskiĭ arkhiv·B A Shelest
Mar 20, 2019·BMC Rheumatology·Seoyoung C KimDaniel H Solomon
Jun 3, 2018·Arthritis Research & Therapy·Alyssa HowrenMary A De Vera
Oct 30, 2018·Journal of the American Heart Association·Yvonne Döring, Emiel P C van der Vorst
Dec 29, 2020·Seminars in Arthritis and Rheumatism·K PathmanathanH I Keen
Nov 18, 2019·Transplantation Proceedings·Mark D BrighamJustin W Li
Jun 26, 2021·Scientific Reports·Diego BenaventEugenio de Miguel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.